Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference28 articles.
1. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients;Jayk Bernal;N Engl J Med,2022
2. Molnupiravir in COVID-19: a systematic review of literature;Singh;Diabetes Metab Syndr,2021
3. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-1: a meta-analysis;Wen;Ann Med,2022
4. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus;Fischer;Sci Transl Med,2022
5. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19;Hammond;N Engl J Med,2022
Cited by 156 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Counterfactual analysis of the 2023 Omicron XBB wave in China;Infectious Disease Modelling;2024-03
2. Real-world Efficacy of Ensitrelvir in Hospitalized Patients with COVID-19 in Japan: A Retrospective Observational Study;2024-02-06
3. Comparison of the incidence of severe outcomes in outpatients with COVID-19 or seasonal influenza without risk factors: Retrospective analysis of a health insurance claims-database;Journal of Clinical Virology Plus;2024-02
4. Retrospective Cohort Study on Determinants of Mechanical Ventilation Duration of COVID-19 ICU Patients;Cureus;2024-01-29
5. Drug effectiveness for COVID-19 inpatients inferred from Japanese medical claim data using propensity score matching;F1000Research;2024-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3